期刊文献+

碘营养水平与甲状腺癌相关性的研究进展

Advances in the relationship between iodine nutrition level and thyroid carcinoma
下载PDF
导出
摘要 碘是甲状腺激素合成的重要原料,并通过甲状腺体现其生理功能。世界卫生组织通过中位尿碘浓度来评估碘营养状态。碘营养水平与甲状腺癌关系暂无明确定论。随着甲状腺癌发生率的逐年增长,碘营养水平与甲状腺癌相关性研究热度也与日俱增。本文将从细胞水平、动物水平、流行病学方面、临床及发病机制上对碘营养水平与甲状腺癌的研究进展进行综述。 Iodine is an important raw material for the synthesis of thyroid hormones and reflects its physiological functions through the thyroid.The World Health Organization uses the median urine iodine concentration to assess iodine nutritional level.The relationship between iodine nutrition level and thyroid cancer is not yet clear.As the incidence of thyroid cancer has increased year by year,the research on the correlation between iodine nutrition and thyroid cancer has also increased.This article will review the research progress of iodine nutrition level and thyroid cancer from cellular level,animal level,epidemiology,clinical and pathogenesis.
作者 王蓓 艾勇彪 王群 袁杰 郑涛 王明华 WANG Bei;AI Yongbiao;WANG Qun;YUAN Jie;ZHENG Tao;WANG Minghua(Postgraduate Training Basement of Jinzhou Medical University,Taihe Hospital,Hubei University of Medicine,Hubei Shiyan 442000,China;Department of Thyroid and Breast Surgery,Taihe Hospital,Hubei University of Medicine,Hubei Shiyan 442000,China)
出处 《现代肿瘤医学》 CAS 北大核心 2023年第7期1348-1352,共5页 Journal of Modern Oncology
关键词 碘营养水平 甲状腺癌 发病机制 iodine nutritional level thyroid carcinoma pathogenesis
  • 相关文献

参考文献5

二级参考文献40

  • 1马霄,30000例地方性甲状腺肿外科治疗,1993年
  • 2McNeil C. Annual cancer statistics report raises key questions [J]. Journal of the National Cancer Institute, 2006,98 (22): 1598.
  • 3Deleu S, Allory Y, Radulescu A, et al. Charact erizat ion of aut onom ou s thyroid aden om a..met aboli sm,gene expression,and pathology[J]. Thyroid, 2000,10,131.
  • 4Heieh AC, Truitt ML, Ruggero D. Oncogenic AK-Tivation of translation as a therapeutic target[J]. Br J Cancer, 2011,105 (3): 329.
  • 5Eisenreich A,Rauch U. PI3K inhibitors in cardiovascular disease [J]. Cardiovasc Ther,2011,29(1) :29.
  • 6Wan X,Helman LJ. The biology behind mTOR inhibition in sar- coma[J]. Oncologist, 2007,12 (8) : 1007.
  • 7Cantley L C. The phosphoinositide 3-kinase pathway[J]. Science, 2002,296(5573) :1655.
  • 8Markman B,Dienstmann R,Tabernero J. Targeting the pi3k/akt /mtor pathway Beyond rapalogs[J]. Oneotarget, 2010,1 (7) : 530.
  • 9Engelman JA, Luo J,Cantley LC. The evolution of phosphatidyli- nositol 3-kinases as regulators of growth and metabolism [J]. NatRev Genet, 2006,7 (8) : 606.
  • 10Dobbin ZC, Landen CN. The importance of the PI3K/AKT / MTOR pathway in the progression of ovarian cancer[J]. Int J Mol Sci,2013,14(4) :8213.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部